KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Q4 2025 value amounting to 0.48.

  • Vertex Pharmaceuticals' Asset Utilization Ratio fell 345.59% to 0.48 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.48, marking a year-over-year decrease of 345.59%. This contributed to the annual value of 0.5 for FY2025, which is 231.93% up from last year.
  • According to the latest figures from Q4 2025, Vertex Pharmaceuticals' Asset Utilization Ratio is 0.48, which was down 345.59% from 0.48 recorded in Q3 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.58 in Q4 2021 and a low of 0.44 during Q1 2024
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.49 (2024), whereas its average is 0.51.
  • As far as peak fluctuations go, Vertex Pharmaceuticals' Asset Utilization Ratio tumbled by 1484.93% in 2023, and later skyrocketed by 1194.19% in 2025.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Asset Utilization Ratio stood at 0.58 in 2021, then dropped by 11.88% to 0.51 in 2022, then decreased by 13.35% to 0.44 in 2023, then grew by 10.87% to 0.49 in 2024, then fell by 3.46% to 0.48 in 2025.
  • Its Asset Utilization Ratio was 0.48 in Q4 2025, compared to 0.48 in Q3 2025 and 0.49 in Q2 2025.